Riskpilot← Back to searchSign inGet full accessMeMamedical AB
ABActiveOrg 5566339817Grev Turegatan 59 CHospital activities · NACE 8610Est. 20020 employees
Revenue 2024
SEK 0
EBITDA margin
—
-3% vs 2023
Equity ratio
63.9%
Financial strength
Net profit 2024
SEK 1,7M
-12% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -125K | -3% |
| Net profit | SEK 1,7M | -12% |
| Total assets | SEK 10,9M | +17% |
| Equity | SEK 7M | +28% |
| Employees | 0 | — |
Legal name
MeMamedical AB
Org number
5566339817
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
14 oktober 2002
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva behandlingar, utbildning och konsultationer inom hälso, sjukvård och pedagogik samt därmed förenlig verksamhet. Förvaltning av fastigheter samt köp och försäljning av värdepapper.
Address
Grev Turegatan 59 C
Phone
+462365421
Email
svemat@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −265 | −124 | −148 | −121 | −125 |
| Depreciation & amort. | −42 | −30 | −21 | −15 | −29 |
| EBIT | −307 | −154 | −169 | −136 | −154 |
| Net financials | 2 132 | 1 706 | 3 034 | 3 096 | 2 628 |
| Profit before tax | 1 376 | 1 332 | 2 315 | 2 510 | 2 224 |
| Tax | −293 | −279 | −452 | −534 | −483 |
| Net profit | 1 083 | 1 053 | 1 863 | 1 976 | 1 741 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 753 | 4 584 | 6 855 | 9 325 | 10 903 |
| Equity | 1 466 | 2 018 | 3 681 | 5 457 | 6 969 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 108 | 166 | 224 | 467 | 285 |
| Total debt | 108 | 166 | 224 | 467 | 285 |
EBITDA margin
-12500000.0%
This company
15.8%
Market median
-79114024% vs market
20202024
Equity ratio
63.9%
This company
38.2%
Market median
+67% vs market
20202024
Return on equity
25.0%
This company
18.4%
Market median
+36% vs market
20202024
Net profit margin
174100000.0%
This company
8.1%
Market median
+2149382616% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
PM Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MeMamedical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Mikael Runsvik | Audit | 0 companies |
| Mats Svensson | Board of Directors | 0 companies |
| Eva Camilla Svensson | Deputy Board Member | 0 companies |
| Meta Ebba Margaretha Svensson | Deputy Board Member | 0 companies |